Literature DB >> 1604823

Differential accumulation of herpes simplex virus type 1 latency-associated transcripts in sensory and autonomic ganglia.

E Rødahl1, J G Stevens.   

Abstract

We have analyzed the capacity of sensory and autonomic ganglia to demonstrate latency-associated transcripts (LATs) following inoculation of the anterior chamber of the mouse eye with Herpes simplex virus type 1 (HSV-1). In autonomic ganglia, the number of LAT-containing neurons decreased 50-fold or more from the acute to the latent phase, while in the trigeminal ganglion, the decrease was less than 2-fold. The decrease in autonomic ganglia could not be related to destruction of neurons expressing LATs, since these ganglia harbored substantial amounts of viral DNA. The data demonstrate that during the latent phase of the infection, accumulation of LATs varies depending on the type of infected neuron and suggest that some neurons may harbor a latent infection in the absence of LAT expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1604823     DOI: 10.1016/0042-6822(92)90721-z

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection.

Authors:  Xiao-Ping Chen; Marina Mata; Mary Kelley; Joseph C Glorioso; David J Fink
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

2.  Herpes Simplex Virus 1 Reactivates from Autonomic Ciliary Ganglia Independently from Sensory Trigeminal Ganglia To Cause Recurrent Ocular Disease.

Authors:  Sungseok Lee; Angela M Ives; Andrea S Bertke
Journal:  J Virol       Date:  2015-08       Impact factor: 5.103

3.  A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation.

Authors:  D C Bloom; J M Hill; G Devi-Rao; E K Wagner; L T Feldman; J G Stevens
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Analysis of the 2-kilobase latency-associated transcript expressed in PC12 cells productively infected with herpes simplex virus type 1: evidence for a stable, nonlinear structure.

Authors:  E Rødahl; L Haarr
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Herpes Simplex Virus 2 in Autonomic Ganglia: Evidence for Spontaneous Reactivation.

Authors:  Julianna R Pieknik; Andrea S Bertke; Philip R Krause
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 6.  Herpes Simplex Virus Latency Is Noisier the Closer We Look.

Authors:  Navneet Singh; David C Tscharke
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

7.  The proportion of trigeminal ganglionic neurons expressing herpes simplex virus type 1 latency-associated transcripts correlates to reactivation in the New Zealand rabbit ocular model.

Authors:  Y J Gordon; E G Romanowski; T Araullo-Cruz; P R Kinchington
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

8.  Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.

Authors:  R Ramakrishnan; D J Fink; G Jiang; P Desai; J C Glorioso; M Levine
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency.

Authors:  J M Hill; B M Gebhardt; R Wen; A M Bouterie; H W Thompson; R J O'Callaghan; W P Halford; H E Kaufman
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

10.  Correlation of virus replication, cytokine (TNF-alpha and IL-1) producing cells, neuronal necrosis and inflammation after intranasal infection of mice with herpes simplex virus strains of different virulence.

Authors:  I Walev; H P Dienes; J Bohl; J Podlech; D Falke
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.